Analyze Diet
Journal of equine veterinary science2024; 143; 105201; doi: 10.1016/j.jevs.2024.105201

A blinded crossover study design to evaluate midazolam as an adjunct for equine standing sedation for routine oral examinations.

Abstract: This study aimed to evaluate the effects of including midazolam to a common equine standing sedation protocol for routine oral examination. Twelve horses underwent two examinations at least seven days apart. Horses were randomly assigned to receive midazolam intravenously (IV) (0.02mg/kg) or a placebo injection of saline (2-2.5mL IV). Five minutes later, detomidine (0.01mg/kg) and butorphanol (0.01mg/kg) were administered IV and horses were placed in standing stocks. A veterinarian blinded to the treatment protocol used a descriptive scoring system to assess degree of ataxia, acceptance of speculum, chewing on the speculum, headshaking, tongue movement, resistance to palpation, and eye appearance as related to the grimace score. During each examination, additional sedation of IV detomidine (0.006mg/kg) and butorphanol (0.006mg/kg) was administered at the discretion of the blinded practitioner to facilitate safe examination. At the second examination horses received the opposite treatment protocol and, following examination, a routine occlusal adjustment. Scores were compared using JMP software with a repeated measures mixed effects model, treatment as a fixed effect and horse and horse/treatment interaction as random effects. Significance was set at P<0.05. There were no significant differences in any of the single or overall sedation scores between treatment groups or within individual horses (P=0.3). Trends towards improvement of some assessed characteristics of sedation, including decreased tongue movement and less resistance to acceptance of speculum were observed. The use of midazolam may prove beneficial for routine oral examination, as well as other standing procedures, with no obvious undesired side effects.
Publication Date: 2024-09-27 PubMed ID: 39341376DOI: 10.1016/j.jevs.2024.105201Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Randomized Controlled Trial
  • Veterinary

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigates the impact of using midazolam, a sedative, as part of a procedure for sedating horses for routine oral exams, utilizing a randomized and blinded crossover design. It concluded that, while there were no significant differences in measures of sedation, some aspects such as decreased tongue movement and acceptance of speculum indicated potential benefits.

Objective and Methodology

  • The central objective of the research was to assess the efficacy of incorporating midazolam into the standard protocol for equine standing sedation during routine oral examinations. Using a blinded crossover study design, two treatments were compared: the administration of midazolam and a placebo (saline).
  • Twelve horses were selected for the study, each undergoing two examinations at an interval of seven days. These horses were randomly assigned to receive either midazolam or saline intravenously. Five minutes later, further sedatives were administered, this being detomidine and butorphanol, and the horses were positioned in standing stocks for the examination.

Examination and Analysis of Sedation Indicators

  • A veterinarian, who was not aware of the treatment protocol, used a scoring system to evaluate various factors related to sedation and responsiveness of the horse, such as the degree of ataxia, acceptance of the speculum, tongue movement, resistance to palpation, and eye appearance compared to the grimace score.
  • During each examination, the blinded practitioner could opt to administer more sedatives, again detomidine and butorphanol, if required for ensuring a safe examination.
  • For the subsequent examination, horses were given the opposite treatment (i.e., if they received midazolam in the first instance, they would receive saline, and vice versa).

Statistical Analysis and Results

  • Data collected during the examinations were statistically analyzed using a repeated measures mixed effects model. The treatment was considered as a fixed effect while the horse and the interaction between horse and treatment were treated as random effects.
  • The results of the study did not show any significant differences in the scores that measured sedation, regardless of whether midazolam or saline was used. This lack of statistical significance was consistent across different treatment groups and within individual horses.

Conclusions and Implications

  • Despite no major differences being statistically proven, the study found some observable trends favoring the use of midazolam. There was a shown reduction in tongue movement and less resistance to speculum acceptance in the midazolam group.
  • The researchers concluded that midazolam could potentially be beneficial in routine oral examinations and other standing procedures for horses – providing these results can be externally validated in further studies – as it did not result in any apparent negative side effects.

Cite This Article

APA
Best ATK, Morgan JM, Burgy CLD, Flynn H, Barter LS, Cassano JM. (2024). A blinded crossover study design to evaluate midazolam as an adjunct for equine standing sedation for routine oral examinations. J Equine Vet Sci, 143, 105201. https://doi.org/10.1016/j.jevs.2024.105201

Publication

ISSN: 0737-0806
NlmUniqueID: 8216840
Country: United States
Language: English
Volume: 143
Pages: 105201

Researcher Affiliations

Best, Amber T K
  • Department of Veterinary Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California, United States.
Morgan, Jessica M
  • Department of Veterinary Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California, United States.
Burgy, Clara L D
  • Department of Veterinary Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California, United States.
Flynn, Harriet
  • Department of Surgical and Radiological Sciences, University of California, Davis, California, United States.
Barter, Linda S
  • Department of Surgical and Radiological Sciences, University of California, Davis, California, United States.
Cassano, Jennifer M
  • Department of Veterinary Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California, United States. Electronic address: jmcassano@ucdavis.edu.

MeSH Terms

  • Animals
  • Female
  • Male
  • Conscious Sedation / methods
  • Conscious Sedation / veterinary
  • Cross-Over Studies
  • Diagnosis, Oral / methods
  • Horses
  • Hypnotics and Sedatives / pharmacology
  • Hypnotics and Sedatives / administration & dosage
  • Midazolam / pharmacology
  • Midazolam / administration & dosage
  • Midazolam / therapeutic use

Conflict of Interest Statement

Declaration of competing interest None.

Citations

This article has been cited 1 times.
  1. Thorn CA, Wilson DV, Wang S, Horne WA. Impact of sequential administration of detomidine, butorphanol, and midazolam on sedation, ataxia, stimulus response, and bispectral index in horses. Front Vet Sci 2025;12:1691137.
    doi: 10.3389/fvets.2025.1691137pubmed: 41200548google scholar: lookup